News
The GOP megabill now under Senate consideration threatens healthcare insurance for more than 1 million seniors who rely on Medicare.
Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...
The Trump administration is reportedly considering a way to ease Medicare and Medicaid into covering GLP-1 drugs like Ozempic ...
Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...
President Trump will deliver remarks from the White House on Wednesday afternoon on the administration’s new “Making Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback